An update in incretin-based therapy: a focus on dipeptidyl peptidase--4 inhibitors. [electronic resource]
Producer: 20120918Description: 169-82 p. digitalISSN:- 1875-6417
- Adamantane -- analogs & derivatives
- Blood Glucose -- drug effects
- Diabetes Mellitus, Type 2 -- blood
- Dipeptides -- pharmacology
- Dipeptidyl-Peptidase IV Inhibitors -- pharmacology
- Drug Interactions
- Female
- Glucagon-Like Peptide 1 -- blood
- Humans
- Linagliptin
- Male
- Nitriles -- pharmacology
- Piperidines -- pharmacology
- Purines -- pharmacology
- Pyrazines -- pharmacology
- Pyrrolidines -- pharmacology
- Quinazolines -- pharmacology
- Sitagliptin Phosphate
- Treatment Outcome
- Triazoles -- pharmacology
- Uracil -- analogs & derivatives
- Vildagliptin
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.